Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam

Encephalopathy resulting from the administration of levetiracetam (LEV) is a rare occurrence. We experienced a patient receiving LEV treated with valproic acid (VPA) for partial seizures with secondary generalization, following which she developed hyperammonemic encephalopathy and showed complete re...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Sook Young, Jang, Hyun-soon, Jeong, Eun Hye, Kim, Byung-Su, Sunwoo, Moon Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Epilepsy Society 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295059/
https://www.ncbi.nlm.nih.gov/pubmed/25625094
http://dx.doi.org/10.14581/jer.14017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295059/
https://www.ncbi.nlm.nih.gov/pubmed/25625094
http://dx.doi.org/10.14581/jer.14017

Ejemplares similares